VMCS - VMCS STOCK NEWS

InnovaQor, Inc. (OTC: VMCS) recently discussed their business activities in an interview. CEO Sharon Hollis emphasized that the company focuses on software development for the healthcare sector, aiming to enhance business practices while offering IT managed services to protect patient data.

The company is prioritizing the monetization of its Electronic Health Records product and is excited about developing a new social media platform for medical professionals that includes subscription services targeting healthcare recruitment, further driving revenue growth.

InnovaQor, Inc. (OTC: VMCS) announced on September 28, 2022, that it has become a fully SEC reporting company as of September 27, 2022. This status was achieved after its Form 10-12G, filed on September 7, became effective. InnovaQor will now file annual reports on Form 10-K, quarterly reports on Form 10-Q, and periodic updates on Form 8-K, complying with additional SEC requirements. CEO Sharon Hollis expressed optimism that this milestone would enhance transparency and attract new shareholders, facilitating revenue growth and profits.

InnovaQor, Inc. (OTC: VMCS) has announced the successful onboarding of a new behavioral health client in Montana for its Medical Mime EHR solution. The transition from an existing EHR will occur over three months, generating implementation fees and ongoing subscription revenue based on user count. CEO Sharon Hollis highlighted the ability to outperform competitors with their modern product focused on customer needs, aimed at increasing efficiency and value for clients. The company projects ongoing sales and revenue growth.

InnovaQor, Inc. (OTC: VMCS) announced that it will become a fully SEC reporting company as its Form 10-12G becomes effective on September 27, 2022. This transition will require the company to file annual reports on Form 10-K, quarterly reports on Form 10-Q, and periodic reports on Form 8-K, enhancing transparency and accountability for shareholders. CEO Sharon Hollis expressed optimism about attracting sophisticated investors and noted plans to change the stock symbol. InnovaQor focuses on innovative technology solutions for the medical sector.

InnovaQor, a company under OTC ticker VMCS, announced the introduction of its Virtual Chief Information Officer (vCIO) services through its subsidiary, Health Technology Solutions (HTS). This service aims to enhance IT security and compliance for healthcare facilities, addressing the growing need for protection against cyber threats. The innovative solutions allow organizations to obtain high-quality IT and cloud resources without incurring the costs of an in-house team. A limited-time offer for a free virtual IT assessment is also available.

InnovaQor (OTC: VMCS) launched an automated implementation process for its Medical Mime EHR solution aimed at rehabilitation and substance abuse treatment centers. This enhancement simplifies transitions from existing EHR systems, addressing operational challenges. The new process minimizes paperwork and time, facilitating implementation within a week without disrupting daily operations. CEO Sharon Hollis emphasizes the growth potential, aiming for market share expansion through improved efficiency.

InnovaQor, Inc. (formerly VisualMed Clinical Solutions, Corp., OTC: VMCS) has officially completed its name change and launched a new website as of September 9, 2021. CEO Sharon Hollis expressed enthusiasm for the rebranding, stating it will better represent their suite of healthcare software solutions. The new website aims to provide updates on products and investor information.

InnovaQor specializes in innovative technology solutions that help medical providers enhance their business processes while safeguarding patient data.

VisualMed Clinical Solutions, soon to be known as InnovaQor, announced a strategy shift following its acquisition from Rennova Health. The new CEO highlighted the company's regained compliance with OTC Markets and the intention to adhere to SEC reporting standards to improve transparency. A name change is planned, alongside the marketing of several software solutions including Advantage, Medical Mime, and Qira, which target efficiency in healthcare delivery. The company aims for immediate financial benefits from these initiatives.

VisualMed Clinical Solutions (OTC: VMCS) has achieved compliance with OTC Markets' disclosure requirements as of August 11, 2021. The company has received confirmation that it has provided the necessary information to remove warning notices related to its shares. Additionally, VisualMed has retained auditors to complete its audited financial statements for the year ending June 30 and plans to meet SEC reporting requirements. CEO Sharon Hollis expressed optimism about improving transparency and launching new software solutions for healthcare.